Ministers as a fully owned company by the Kuwait Investment Authority (KIA), the sovereign wealth fund of the State of Kuwait. Capitalized at 100 million Kuwait Dinars (KD) which is equivalent to approximately $350 million US Dollars, NTEC aims to play a vital role in servicing major stakeholders in Kuwait and the Middle East region with their technology requirements.

KLSC focuses on healthcare innovative concepts and demanded services which have a clear and unmet need in the Middle East and North Africa (MENA) region. KLSC has been designed as an integrated healthcare company building unique projects and is considered one of the pioneer venture capitalist and private equity companies in the Middle East that invests globally and operates regionally seeking to advance healthcare services and systems within the region. KLSC supports both public and private sector stakeholders to access emerging technologies, establish unique projects and adapt best practices prevailing in today’s healthcare field. KLSC operates in healthcare investment, life sciences training, medical technology and pharmaceutical distribution.

Investment Strategy

KLSC follows a similar investment strategy according to its parent company, NTEC, focusing on the following three pillars –

1) Incubation (Start Up) Projects – Local and Regional

2) Venture Capital – International

3) Private Equity – Regional and International

Incubation (Start Up) Projects – Local and Regional

KLSC invests in the project’s equity in partnership with the private sector entrepreneur or company and accommodates KLSC’s main strategic goal of technology transfer into Kuwait and the MENA region.

These projects are internally developed by KLSC and externally developed by the private sector. In both cases, KLSC usually favors the formation of a Joint Venture, partnering with technology providers, supporting projects that add value, meet a local or regional demand and are an internationally proven concept.

Examples already developed by KLSC include:

Life Sciences Academy – a knowledge transfer platform

Innomedics – a medical devices commercialization platform

Newbridges – a pharmaceutical commercialization platform

Venture Capital – International

KLSC invest in companies with products or services which solve existing customer problems with ground-breaking technologies and have the potential for above average, substantial growth.

Through many years of experience in direct venture capital investments and investing in world class venture capital funds, KLSC has developed a systematic process based on proprietary thought selection, comprehensive due diligence, and an active investment management.

The focus is pre-commercialization stage companies that are viable and financially attractive with clear exit strategies and a vision to expand into new markets such as Kuwait and the MENA region.

Examples of investments by KLSC include:

Quanta Fluid Solutions – a market leader in (home) hemodialysis solutions

Supersonic Imagine – a market leader in ultrasound imaging

Median Technologies – a market leader in oncology monitoring and imaging

Private Equity – Regional and International

KLSC also invests in more established companies with the purpose of reducing the time gap of certain in-demand technology introduction into the mass markets that follow the existing technology transfer platforms identified by KLSC for the Life Sciences Industry.

KLSC invests in the form of private equity in established life science and healthcare companies that have the potential of regional expansion, and a proven concept with sustainable business model.

Examples of investments by KLSC include:

Clinart – a clinical research (contract resource organization) platform

eCore – an industrial (specialty chemicals) platform